These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 88985)

  • 41. Autoradiographic studies of androgen-binding sites in human benign prostatic hyperplasia in vitro.
    Lasnitzki I; Takeda H; Mizuno T
    J Endocrinol; 1989 Jan; 120(1):167-70. PubMed ID: 2465368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Partial characterization of [3H]methyltrienolone binding in rat prostate cytosol.
    Pousette A; Snochowski M; Bression D; Högberg B; Gustafsson JA
    Biochim Biophys Acta; 1979 Jan; 582(2):358-67. PubMed ID: 760830
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantification of androgen binding, androgen tissue levels, and sex hormone-binding globulin in prostate, muscle and plasma of patients with benign prostatic hypertrophy.
    Krieg M; Bartsch W; Herzer S; Becker H; Voigt KD
    Acta Endocrinol (Copenh); 1977 Sep; 86(1):200-15. PubMed ID: 71838
    [No Abstract]   [Full Text] [Related]  

  • 44. Binding of Permixon, a new treatment for prostatic benign hyperplasia, to the cytosolic androgen receptor in the rat prostate.
    Carilla E; Briley M; Fauran F; Sultan C; Duvilliers C
    J Steroid Biochem; 1984 Jan; 20(1):521-3. PubMed ID: 6200701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Androgen receptor assays in advanced prostatic cancer.
    Buttyan R; Olsson CA
    Urol Clin North Am; 1984 May; 11(2):311-7. PubMed ID: 6375068
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Androgen receptors in cytosol in benign prostatic hyperplasia].
    Corrales Hernandez JJ; Miralles Garcia JM; Montero Gomez J; Martin T; Martin Rodriguez M; Gonzalez Buitrago JM
    Rev Clin Esp; 1983 Feb; 168(4):233-7. PubMed ID: 6190202
    [No Abstract]   [Full Text] [Related]  

  • 47. Cytoplasmic and nuclear androgen receptor content of normal and neoplastic human prostates and lymph node metastases of human prostatic adenocarcinoma.
    Shain SA; Boesel RW; Lamm DL; Radwin HM
    J Clin Endocrinol Metab; 1980 Apr; 50(4):704-11. PubMed ID: 6154061
    [No Abstract]   [Full Text] [Related]  

  • 48. Mechanism of androgen-receptor augmentation. Analysis of receptor synthesis and degradation by the density-shift technique.
    Syms AJ; Norris JS; Panko WB; Smith RG
    J Biol Chem; 1985 Jan; 260(1):455-61. PubMed ID: 3871197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Binding of androgens and progestins in the human testis.
    Støa KF; Hekim N; Dahl O; Høisaeter PA
    J Steroid Biochem; 1979 Jul; 11(1A):261-5. PubMed ID: 491594
    [No Abstract]   [Full Text] [Related]  

  • 50. Characterization of the binding of a potent synthetic androgen, methyltrienolone, to human tissues.
    Menon M; Tananis CE; Hicks LL; Hawkins EF; McLoughlin MG; Walsh PC
    J Clin Invest; 1978 Jan; 61(1):150-62. PubMed ID: 73547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differences in the physicochemical characteristics of androgen-receptor complexes formed in vivo and in vitro.
    Traish AM; Müller RE; Wotiz HH
    Endocrinology; 1984 May; 114(5):1761-9. PubMed ID: 6609069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The baboon prostate as a model for steroid hormone receptors in the human gland.
    Karr JP; Kirdani RY; Murphy GP; Sandberg AA
    Prog Clin Biol Res; 1979; 33():165-79. PubMed ID: 119228
    [No Abstract]   [Full Text] [Related]  

  • 53. Human prostate androgen receptor quantitation: effects of temperature on assay parameters.
    Shain SA; Gorelic LS; Boesel RW; Radwin HM; Lamm DL
    Cancer Res; 1982 Nov; 42(11):4849-54. PubMed ID: 6982098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hormonal regulation in two rat mammary cancer cell lines: glucocorticoid and androgen receptors.
    Vignon F; Chan PC; Rochefort H
    Mol Cell Endocrinol; 1979 Feb; 13(2):191-202. PubMed ID: 109329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Binding of [3H]-methyltrienolone (R1881) by human breast cancers.
    Miller WR; Telford J; Hawkins RA
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1473-8. PubMed ID: 6605855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Familial external genital ambiguity due to a transformation defect of androgen-receptor complexes that is expressed with 5 alpha-dihydrotestosterone and the synthetic androgen methyltrienolone.
    Kaufman M; Pinsky L; Bowin A; Au MW
    Am J Med Genet; 1984 Jul; 18(3):493-507. PubMed ID: 6332533
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Stabilization of androgen receptor by nonandrogenic steroids.
    Nemoto T; Ohara-Nemoto Y; Sato M; Ota M
    Biochem Int; 1986 May; 12(5):701-5. PubMed ID: 3488063
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prostatic cytoplasmic androgen receptor in prostatic disease. II. Correlation between clinical response to hormonal therapy and change of R1881 receptor content in prostatic cancer during antiandrogenic therapy].
    Kitano T
    Nihon Hinyokika Gakkai Zasshi; 1984 Jul; 75(7):1098-108. PubMed ID: 6334193
    [No Abstract]   [Full Text] [Related]  

  • 59. [Correlations between DHT levels and NBS of R1881 receptor in total tissue, cytosol and nuclear extract of human prostate].
    Morioka M; Ohashi Y; Fujita Y; Takeda K; Tojo S; Ohashi T; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1984 Jan; 75(1):96-103. PubMed ID: 6204091
    [No Abstract]   [Full Text] [Related]  

  • 60. Androgen binding in cytosols and nuclei of human benign hyperplastic prostatic tissue.
    Sirett DA; Grant JK
    J Endocrinol; 1978 Apr; 77(1):101-10. PubMed ID: 76668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.